Vaccine Technologies HIV vaccine LFn-p24B/C displays immunogenicity in phase I study July 14, 2016 No Comments
Gilead Sciences and Institute of Organic Chemistry and Biochemistry patent anti-HIV agents July 12, 2016 No Comments
RSS